15.JPG)
The Smart Syringes Market Size is valued at USD 67.29 Mn in 2023 and is predicted to reach USD 145.62 Mn by the year 2031 at a 10.21% CAGR during the forecast period for 2024-2031.
The increased cases of chronic diseases, including diabetes, cancer, and autoimmune disorders, drive the demand for smart syringes, which are used to give medications and immunizations. Due to the advancement of cutting-edge technologies like auto-disable syringes, prefilled syringes, and needle-free injectors, the market for smart syringes is growing. Because pediatric patients are increasing annually and this age group is more sensitive to infectious diseases, paediatrics is the most lucrative subspecialty.
Significant growth is projected due to the rising prevalence of several target diseases, the rising vaccination rate, the rise in the number of older adults, and the necessity to prevent infections that can be contracted in hospitals or clinics.
Additionally, the market for smart syringes is expanding as more hospitals and health maintenance organizations (HMOs) around the world are adopting smart syringes. In addition, smart syringes are also being used by mental and diabetic patients more frequently to prevent needle stick injuries.
The senior population is predicted to experience chronic diseases due to age-related risk factors and ongoing adoption of poor lifestyle habits. As a result of this rise in diseases, it is anticipated that utilization rates of syringes in the market will increase. The significant unmet needs in many developing nations and the change in healthcare systems toward safe injection techniques offer enormous market growth potential, which is anticipated to fuel the use of smart syringes over the forecast period.
The Smart Syringes market is segmented based on product, volume and application. Based on product, the Smart Syringes market is segmented as with and without needles. The market is segmented by volume into below 1000 μL and above 1000 μL. By application, the Smart Syringes market is segmented into medical use and non-medical use.
The needle type category will hold a major share of the global Smart Syringes market 2022. The rising usage of needle-type smart syringes in the healthcare industry reflects a growing trend toward improving patient safety, medication administration accuracy, and healthcare efficiency. Smart syringes are medical devices designed with features that enhance their functionality, reduce the risk of needlestick injuries, and ensure proper dosing of medications. These devices incorporate various technologies to provide benefits such as automatic retraction of needles, digital dose measurement, and connectivity for data tracking and analysis.
The medical use segment is projected to grow rapidly in the global Smart Syringes market. The rising use of smart syringes in the medical field is driven by various factors contributing to enhanced patient safety, improved healthcare outcomes, and increased efficiency in medical procedures. Smart syringes integrate advanced technologies and features beyond traditional syringes, offering benefits such as precision dosing, connectivity, data collection, and enhanced infection control.
The North America Smart Syringes market is expected to register a tremendous market share. The market is anticipated to grow even more in the upcoming years due to ongoing improvements in medical practices at healthcare facilities around the area.
The American region is anticipated to experience considerable expansion due to rising private and public medical costs, better healthcare facilities, and increased awareness of the risks associated with using hazardous syringes. In addition, Asia Pacific is projected to grow rapidly in the global smart syringes market. The main factors supporting the market expansion over the projection period are increases in public and private healthcare expenditure levels to support initiatives to stop disease transmission and improve patient care.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 67.29 Mn |
|
Revenue Forecast In 2031 |
USD 145.62 Mn |
|
Growth Rate CAGR |
CAGR of 10.21 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Volume, Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Agilent Technologies, Inc., Schott AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Trajan LEAP PAL Parts + Consumables, Clayens-np, Becton, Dickinson and Co., B. Braun Melungeon AG, Terumo Medical Corporation, Baxter International, Inc, Retractable Technologies, Inc, Smith's Group Plc, Merck & Company Inc., Medtronic Plc (Covidien), Unilife Corporation, Revolutions Medical Corporation, AdvaCare Pharma, Cardinal Health, Parker Hannifin Corp., Numedico Technologies Pty Ltd, Thomas Scientific (U.S), McKesson Medical-Surgical Inc. (U.S) |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Smart Syringes Market Snapshot
Chapter 4. Global Smart Syringes Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type:
5.2.1. With Needle
5.2.1.1 Fixed
5.2.1.2 Exchangeable
5.2.2. Without Needle
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:
6.2.1. Medical Use
6.2.1.1. Drug Delivery
6.2.1.2. Blood Sample Collection
6.2.1.3. Vaccination
6.2.2. Non-medical Use
Chapter 7. Market Segmentation 3: By Volume Estimates & Trend Analysis
7.1. By Type & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Volume:
7.2.1. Below 1000 μL
7.2.2. Above 1000 μL
Chapter 8. Smart Syringes Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Type, 2023-2031
8.1.2. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
8.1.3. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031
8.1.4. North America Smart Syringes Market revenue (US$ Million) estimates and forecasts By country, 2023-2031
8.1.4.1. U.S.
8.1.5. Canada
8.2. Europe
8.2.1. Europe Smart Syringes Market revenue (US$ Million) By Type, 2023-2031
8.2.2. Europe Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
8.2.3. Europe Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031
8.2.4. Europe Smart Syringes Market revenue (US$ Million) By country, 2023-2031
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Smart Syringes Market revenue (US$ Million) By Type, 2023-2031
8.3.2. Asia Pacific Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
8.3.3. Asia Pacific Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031
8.3.4. Asia Pacific Smart Syringes Market revenue (US$ Million) By country, 2023-2031
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Smart Syringes Market revenue (US$ Million) By Type, 2023-2031
8.4.2. Latin America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
8.4.3. Latin America Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031
8.4.4. Latin America Smart Syringes Market revenue (US$ Million) By country, (US$ Million) 2023-2031
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Smart Syringes Market revenue (US$ Million) By Type, (US$ Million)
8.5.2. Middle East & Africa Smart Syringes Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
8.5.3. Middle East & Africa Smart Syringes Market revenue (US$ Million) estimates and forecasts By Volume, 2023-2031
8.5.4. Middle East & Africa Smart Syringes Market revenue (US$ Million) By country, (US$ Million) 2023-2031
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Agilent Technologies, Inc.
9.2.2. Schott AG
9.2.3. Shimadzu Corporation
9.2.4. Thermo Fisher Scientific Inc.
9.2.5. Trajan LEAP PAL Parts + Consumables
9.2.6. Clayens-np
9.2.7. Becton, Dickinson and Co.
9.2.8. B. Braun Melungeon AG
9.2.9. Terumo Medical Corporation
9.2.10. Baxter International, Inc
9.2.11. Retractable Technologies, Inc
9.2.12. Smith's Group Plc
9.2.13. Merck & Company Inc.
9.2.14. Medtronic Plc (Covidien)
9.2.15. Unilife Corporation
9.2.16. Revolutions Medical Corporation
9.2.17. AdvaCare Pharma
9.2.18. Cardinal Health
9.2.19. Parker Hannifin Corp.
9.2.20. Numedico Technologies Pty Ltd
9.2.21. Thomas Scientific (U.S),
9.2.22. McKesson Medical-Surgical Inc. (U.S)
Smart Syringes Market By Product
Smart Syringes Market By Volume
Smart Syringes Market By Application
Smart Syringes Market By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
